The ELFIE-HYPERTENSION Trial: An international randomized multicenter trial of an artificial intelligence enhanced and gamified mobile health intervention for hypertension management

30 August 2026 (17:45 - 18:00)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Karla Santo

Albert Einstein Israelite Hospital, Sao Paulo (Brazil)

3 More presentations in this session

Presentation thumbnail

Efficacy and safety of sacubitril/allisartan plus amlodipine in hypertensive patients not adequately controlled by amlodipine or sacubitril/allisartan monotherapy: the SALUS study

Professor J. Li (Beijing, CN)

Presentation thumbnail

Blood pressure management with an artificial intelligence-enhanced app and wearable devices: My Intelligent Cardiac Assistant (MICArdiac) Randomised Controlled Trial

Doctor L. Laranjo (Sydney, AU)

Presentation thumbnail

Chemical adherence testing-guided intervention is cost-effective in management of non-adherence to antihypertensive treatment - life-time evaluation of OUTREACH Study

Doctor S. Hames-Fathi (Manchester, GB)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 17:45 CET

You may be interested in

Congress Presentation

The past, present, and future of digital blood pressure-lowering interventions

31 August 2025

Congress Presentation

Artificial intelligence empowered digital platform to support patients with heart failure (AZIMUTH platform)

22 May 2023

Webinar

Innovation in the cloud: see what artificial intelligence can do for ICMs

20 July 2022

Congress Presentation

Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.

5 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources